Skip to main content

Year: 2022

Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System

HINGHAM, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced a significant development milestone as it completed the GLP animal study for the LIBERTY® Robotic System, the first disposable robotic system being developed for endovascular procedures. The study was performed by a team of seasoned Key Opinion Leaders (KOLs) in the endovascular space at a world-class MedTech research laboratory with FDA-required levels of planning, controlling, monitoring, and reporting (GLP standards), using porcine model. During the GLP animal study, the physicians conducted pre-determined 63 navigations to the targeted sites using the investigational LIBERTY Robotic System and performed an equal number of procedures manually. The performance endpoint of the LIBERTY Robotic System after robotic navigation was successfully...

Continue reading

Smart For Life Announces Initiation of Equity Analyst Coverage by Dawson James Securities

Initiates with “Buy” recommendation and $8 price target MIAMI, Oct. 13, 2022 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that Jason H. Kolbert, Managing Director & Senior Analyst at Dawson James Securities, has initiated research coverage on the Company with a “Buy” recommendation and $8 price target. The report is available for download on the Dawson James Securities website. Any opinions, estimates or forecasts by Dawson James Securities regarding the Company’s performance are theirs alone and do not represent opinions, forecasts or predictions of Smart for Life or its management. Smart for Life does not by its reference above...

Continue reading

Cyclacel Pharmaceuticals To Present Preliminary Data From The Phase 1/2 Clinical Trial Of Oral Fadraciclib At The 34th EORTC-NCI-AACR Symposium

– Preliminary Dose Escalation Data to be Presented on Novel CDK2/9 Inhibitor Fadraciclib in Patients with Solid Tumors and Lymphoma – BERKELEY HEIGHTS, N.J., Oct. 13, 2022 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced it will present preliminary dose escalation data from its ongoing 065-101 Phase 1/2 clinical trial of oral fadraciclib for the treatment of patients with advanced solid tumors and lymphoma during a poster presentation at the upcoming 34th EORTC-NCI-AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics, which is being held on October 26-28th, 2022, in Barcelona, Spain. Details of the presentation are...

Continue reading

Pineapple Energy Reports Inducement Grant to New Chief Financial Officer

MINNETONKA, Minn., Oct. 13, 2022 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (“Pineapple,” “Pineapple Energy” or the “Company”), a leading provider of sustainable solar energy and back-up power to households and small businesses, announced today, as required by Nasdaq Listing Rule 5635(c)(4), that in connection with the appointment of Eric Ingvaldson as the Company’s Chief Financial Officer effective October 10, 2022, Mr. Ingvaldson received a grant of an inducement award on October 11, 2022. As an inducement for Mr. Ingvaldson to enter into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4), Pineapple’s compensation committee approved the grant to Mr. Ingvaldson of 82,278 restricted stock units (“RSUs”). This award was made outside of the Company’s 2022 Equity Incentive Plan, but is subject to the same...

Continue reading

EzFill Holdings Recognized by Governor’s Office for Hurricane Recovery Efforts

MIAMI, FL, Oct. 13, 2022 (GLOBE NEWSWIRE) — EzFill Holdings, Inc. (“EzFill” or the “Company”) (NASDAQ: EZFL), a pioneer and emerging leader in the mobile fuel industry, continues its efforts to assist the Fort Myers area in the efforts to recover from the impact of Hurricane Ian. On October 8, Florida Governor Ron DeSantis traveled to Fort Myers Beach to give updates on recovery efforts. Among the response efforts noted were the private sector support provided by many Florida based companies, including EzFill Holdings, which was recognized for delivering fuel daily for firefighter volunteers and first responder vehicles in Bonita Springs, delivering fuel to homes of residents in Cape Coral, as well as filling generators, cars and gas cans. EzFill partnered with Simply Healthcare to provide fuel for healthcare workers at Lee County...

Continue reading

Brunswick Corporation Named to the 2022 Forbes “World’s Best Employers” list for Third Consecutive Year

METTAWA, Ill., Oct. 13, 2022 (GLOBE NEWSWIRE) — For the third consecutive year, Brunswick Corporation (NYSE:BC) has been named by Forbes and Statista to the 2022 list of World’s Best Employers. Among the thousands of global companies surveyed for this honor, Brunswick ranked in the top 15 percent of all organizations, placing No. 104 of 800 companies overall – an improvement of 12 positions compared to 2021. Additionally, Brunswick ranked in the top 10 companies in the world within the Engineering and Manufacturing category. To compile this ranking, Statista surveyed 150,000 full-time and part-time workers from 57 countries working for multinational companies and institutions to determine those excelling in corporate impact and image, talent development, gender equality and social responsibility. “We are thrilled to be named to...

Continue reading

Enerflex Ltd. Completes Acquisition of Exterran Corporation, Establishing a Premier Integrated Global Provider of Energy Infrastructure and Energy Transition Solutions

CALGARY, Alberta, Oct. 13, 2022 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”), a leading supplier of vertically integrated products and services to the global energy industry, is pleased to announce today that it has completed its acquisition of Exterran Corporation (“Exterran”), a leader in natural gas processing and treatment and compression products and services (the “Transaction”). Enerflex’s common shares will continue to trade on the Toronto Stock Exchange (“TSX”) under the symbol “EFX”, and the Company will commence trading on the New York Stock Exchange (“NYSE”) under the symbol “EFXT” on October 13, 2022. Enerflex is a premier integrated global provider of energy infrastructure...

Continue reading

Calgary-Based Avenue Living Reaches 15,000 Multi-Family Units Under Management Across North American Heartland

Sees Potential for Further Expansion in Key LocationsAvenue Living’s AUM Growth to $4B AUM Since 2006Calgary, AB, Oct. 13, 2022 (GLOBE NEWSWIRE) — All financial figures are in U.S. dollars Calgary-based Avenue Living is pleased to announce that following the recent acquisition of a 386-unit property worth $52 million in Columbus, Georgia, it has reached a milestone of 15,000 multi-family homes under ownership in 23 regions across North America.  The purchase reinforces Avenue Living’s 16-year, proven consolidation strategy, which focuses on low-to-medium density workforce housing located in key markets. The company continues to target moderate growth markets that exhibit a diversified economic base and low institutional penetration.    “Since entering the multi-family space in 2006, we’ve focused on creating an operating...

Continue reading

Progressive Reports September 2022 Results

MAYFIELD VILLAGE, OHIO, Oct. 13, 2022 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for September 2022 and the third quarter of 2022:  September     Quarter    (millions, except per share amounts and ratios; unaudited)  2022       2021     Change   2022       2021   Change                   Net premiums written $ 4,007.3     $ 4,004.0     0 % $ 13,017.8     $ 12,446.5   5 %Net premiums earned $ 3,869.5     $ 3,537.5     9 % $ 12,398.9     $ 11,364.8   9 %Net income (loss) $ (684.4 )   $ (130.3 )   425 % $ 124.1     $ 118.5   5 %Per share available to common shareholders $ (1.17 )   $ (0.23 )   418 % $ 0.20     $ 0.19   5 %Total pretax net realized gains (losses) on securities $ (351.0 )   $ (217.4 )   61 % $ (216.4 )   $ 36.8   NMCombined ratio   116.2       100.1     16.1...

Continue reading

Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update

– Q3 2022 Consolidated Revenue Growth of 17% to $20.8 million – Q3 2022 North American Revenue Growth of 19% – TH1902 Phase 1 basket trial proceeding as planned – On track to meet FY2022 Revenue Guidance $79 – $82 million MONTREAL, Oct. 13, 2022 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today reported business highlights and financial results for the third quarter of fiscal year 2022, ended August 31, 2022. All figures are in U.S. dollars unless otherwise stated. “We kicked off the third quarter with many exciting developments and spent the remaining period focusing on strategic growth, corporate alignment and shareholder outreach. As...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.